Tumour necrosis factor 308 polymorphisms and hepatocellular carcinoma risk: A meta-analysis

Hepato-Gastroenterology

Volumn 57, Issue 101, 2010, Pages 926-931

  Guo, Yan Mei ^a   Wei, Wei Yu ^b   Shen, Xi Zhong ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Gene; Hepatocellular carcinoma (HCC); Meta analysis; Polymorphisms; Tumour necrosis factor (TNFA)

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER RISK; ETHNICITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; GENE FREQUENCY; HUMANS; LIVER NEOPLASMS; ODDS RATIO; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78149259848     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Farazi PA, DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006 Sep; 6(9):674-687.
2. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management of hepatocellular carcinoma. conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver. J Hepatol 2001 Sep; 35(3):421-430.
3. Llovet JM, Bruix J: Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008; 48 Suppl 1:S20-37.
4. Lee JS, Thorgeirsson SS: Comparative and integrative functional genomics of HCC. Oncogene 2006 Jun 26; 25(27):3801-3809.
5. Bosch FX, Ribes J, Diaz M, Cleries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004 Nov; 127(5 Suppl 1):S5-S16.
6. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997 Apr 1; 94(7):3195-3199.
7. Tokushige K, Takakura M, Tsuchiya-Matsushita N, Taniai M, Hashimoto E, Shiratori K: Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol 2007 Jun; 46(6):1104-1110.
8. Yuan Y, Sun M, Li KS: Astragalus mongholicus polysaccharide inhibits lipopolysaccharide-induced production of TNF-alpha and interleukin-8. World J Gastroenterol 2009 Aug 7; 15(29):3676-3680.
9. Melo Barbosa HP, Martins LC, Dos Santos SE, Demachki S, Assumpcao MB, Aragao CD, de Oliveira Corvelo TC: Interleukin-1 and TNF-alpha polymorphisms and helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol 2009 Mar 28; 15(12):1465-1471.
10. Thakkinstian A, McEldu P, D'Este C, Du D, and Attia J: A method for meta-analysis of molecular association studies. Statist Med 2005; 24:1291-1306.
11. Lau J, Ioannidis JP, Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127(9):820-826.
12. Higgins J, Thompson S, Deeks J, Altman D: Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
13. Whitehead A, Whitehead J: A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10:1665-1677.
14. Ognjanovic S, Yuan JM , Chaptman AK, Fan Y, Yu MC: Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA. Carcinogenesis 2009; 30(5):758-62.
15. Niro GA, Fontana R, Gioffreda D, Valvano MR, Lacobellis A, Facciorusso D, Andriulli A: Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int 2005 Dec; 25(6):1175-1181.
16. Heneghan MA, Johnson PJ, Clare M, Ho S, Harrison PM, Donaldson PT: Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. Int J Gastrointest Cancer 2003; 34(1):19-26.
17. Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S, Tanaka K: Interaction between interleukin-1beta -31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese. Cancer Lett 2008 Nov 18; 271(1): 98-104.
18. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N: Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 2007 Dec; 14(12):841-848.
19. Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG: Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 2007 Nov; 9(11):987-992.
20. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW: Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol 2005 Dec; 34(6):1310-1318.
21. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, Hamasaki K, Yatsuhashi H, Ishibashi H, Eguchi K: Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol 2005 Apr; 42(4):505-510.
22. Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR: Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 2004 Sep; 15(7):657-663.
23. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, Goto T, Moriyama M, Otsuka M, Shiina S, Shiratori Y, Ito Y, Omata M: Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 2003 Jan; 37(1):65-71.
24. Song SF, Gao Yh, Chen SD: Interaction of TNF-α-308 and environmental risk factors in primary liver cancer. J of Guangdong Pharmaceutical College. Apr.2009; 25(2):196-201. (In Chinese with English abstract).
25. Balkwill F: Tumor necrosis factor or tumor promoting factor. Cytokine Growth Factor Rev 2002; 13(2):135-141.
26. Biological Therapies: Using the Immunse System to Treat Cancer. 1995 [cited; Error! Hyperlink reference not valid.]. Available from: http://cancerweb.ncl.ac.uk/cancernet/600072.html
27. Gantner F, Leist M, Jilg S, Germann PG, Freudenberg MA, Tiegs G: Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995 Jul; 109(1):166-176.
28. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A: Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994 Aug 15; 153(4):1778-1788.
29. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP: Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997 Jan 18; 349(9046):170-173.
30. Wilson AG, Duff GW: Genetic traits in common diseases. BMJ 1995 Jun 10; 310(6993):1482-1483.
31. Zhang J, Dou C, Song Y, Ji C, Gu S, Xie Y, Mao Y: Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis. J Hum Genet 2008; 53(6):479-489.
32. Medica I, Kastrin A, Maver A, Peterlin B: Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis. J Hum Genet 2007; 52(10):836-847. (Pubitemid 47512856)
33. Li N, Zhou Z, Liu X, Liu Y, Zhang J, Du L, Wei M, Chen X: Association of tumour necrosis factor alpha (TNF-alpha) polymorphisms with Graves' disease: A meta-analysis. Clin Biochem 2008 Jul; 41(10-11):881-886.
34. Castro-Giner F, Kogevinas M, Machler M, de Cid R, Van Steen K, Imboden M, Schindler C, Berger W, Gonzalez JR, Franklin KA, Janson C, Jarvis D, Omenaas E, Burney P, Rochat T, Estivill X, Anto JM, Wjst M, Probst-Hensch NM: TNFA-308G>A in two international population-based cohorts and risk of asthma. Eur Respir J 2008 Aug; 32(2):350-361.
35. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, Labib T, Taing L, Sladek R, Deveau C, Ratsimandresy R, Montes M, Spadoni JL, Lelievre JD, Levy Y, Therwath A, Schachter F, Matsuda F, Gut I, Froguel P, Delfraissy JF, Hercberg S, Zagury JF: Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009 Feb 1; 199(3):419-426.
36. Lu Z, Chen L, Li H, Zhao Y, Lin L: Effect of the polymorphism of tumor necrosis factor-alpha-308 G/A gene promoter on the susceptibility to ulcerative colitis: a meta-analysis. Digestion 2008; 78(1):44-51.